Marjolijn N. Lub‐de Hooge

Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab

Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik et al. · British Journal of Pharmacology · 2004 · 177 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery

Marta M. Kijanka, Frank-Jan Warnders, Mohamed El Khattabi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 143 citations

Medicine, Oncology, Surgery +14

Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue

Danique Giesen, Linda N. Broer, Marjolijn N. Lub‐de Hooge et al. · Clinical Cancer Research · 2020 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

⁸⁹Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs

Elly L. van der Veen, Danique Giesen, Linda Pot-de Jong et al. · Journal for ImmunoTherapy of Cancer · 2020 · 48 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody

Laura Kist de Ruijter, Jahlisa S. Hooiveld-Noeken, Danique Giesen et al. · Clinical Cancer Research · 2021 · 44 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17